Hormonal Treatment of Endometriosis: A Narrative Review
Pharmaceuticals · 17.04.2025 · 18 (4) · 588
DOI: 10.3390/ph18040588 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 17.04.2025. Verfasst von Elvin Piriyev und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Gynecology and Obstetrics, University Witten-Herdecke, 58455 Witten, Germany. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endometriosis is one of the most common gynecological diseases, affecting up to 10–15% of women of reproductive age. It is a chronic, estrogen-dependent condition that often presents with heterogeneous symptoms, complicating diagnosis and delaying treatment.
Methods
This is a narrative review based on a comprehensive analysis of recent literature regarding hormonal treatment options for endometriosis, including primary and adjuvant therapies.
Results
Combined oral contraceptives (COCs) are effective in reducing dysmenorrhea, but show limited benefit for other symptoms and may not prevent disease progression. Progestins, particularly dienogest, demonstrate superior long-term efficacy with favorable side-effect profiles. GnRH agonists and antagonists are reserved for second-line treatment due to side effects and hypoestrogenism, but can significantly reduce endometriotic lesions. The levonorgestrel intrauterine system (LNG-IUS) is especially effective in patients with adenomyosis.
Conclusions
Hormonal therapies are central to the management of endometriosis. Progestins are considered the most suitable long-term option. Despite promising results, evidence quality varies, and further studies are needed to establish long-term efficacy, patient-specific outcomes, and direct comparisons between agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair of Gynecology and Obstetrics, University Witten-Herdecke, 58455 Witten, Germany.
- Department of Obstetrics and Gynecology, Academic Hospital Cologne Weyertal, University of Cologne, Weyertal 76, 50931 Cologne, Germany.
- Chair of Gynecology and Obstetrics, University of Cologne, 50923 Cologne, Germany.
ORCID-Profile: Elvin Piriyev
Zitieren
APA
Piriyev, E., Schiermeier, S., & Römer, T. (2025). Hormonal Treatment of Endometriosis: A Narrative Review. Pharmaceuticals, 18(4), 588. https://doi.org/10.3390/ph18040588
Vancouver
Piriyev E, Schiermeier S, Römer T. Hormonal Treatment of Endometriosis: A Narrative Review. Pharmaceuticals. 2025;18(4):588. doi:10.3390/ph18040588
BibTeX
@article{Piriyev2025,
author = {Piriyev, Elvin and Schiermeier, Sven and Römer, Thomas},
title = {Hormonal Treatment of Endometriosis: A Narrative Review},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {4},
pages = {588},
doi = {10.3390/ph18040588}
}
EUVIMED